FTC sues to block Amgen acquisition of Horizon Therapeutics

  • 📰 CNBC
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 72%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

The deal was a bid to strengthen Amgen's drug portfolio as it prepares to face several patent expirations for key treatments over the next decade.

Sources familiar with the matter told CNBC's David Faber earlier Tuesday that Amgen is prepared to defend the acquisition, with one source adding the company expects to "win big."

Representatives for Amgen and for Horizon Therapeutics did not immediately respond to a request for comment from CNBC.The two drugmakers said in February that the FTC sent themThousand Oaks, California-based Amgen to buy Horizon Therapeutics in early December and said it expected to complete the sale in the first half of this year.for key treatments over the next decade.CNBC Health & Science

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 12. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Robocall company behind 'billions' of illegal calls sued by FTCXCast Labs, a company accused of helping make billions of illegal robocalls, was sued on Friday by the U.S. Federal Trade Commission, which asked the court to order the company to stop the practice.
출처: Reuters - 🏆 2. / 97 더 많은 것을 읽으십시오 »